InhaleRx Past Earnings Performance
Past criteria checks 0/6
InhaleRx has been growing earnings at an average annual rate of 4.6%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 57.9% per year.
Key information
4.6%
Earnings growth rate
28.7%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 57.9% |
| Return on equity | n/a |
| Net Margin | -85.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How InhaleRx makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -1 | 1 | 0 |
| 31 Mar 24 | 1 | -1 | 1 | 1 |
| 31 Dec 23 | 1 | -1 | 1 | 1 |
| 30 Sep 23 | 1 | -2 | 1 | 2 |
| 30 Jun 23 | 0 | -2 | 1 | 2 |
| 31 Mar 23 | 0 | -2 | 1 | 1 |
| 31 Dec 22 | 0 | -2 | 1 | 1 |
| 30 Sep 22 | 0 | -2 | 1 | 1 |
| 30 Jun 22 | 0 | -1 | 1 | 1 |
| 31 Mar 22 | 0 | -1 | 1 | 0 |
| 31 Dec 21 | 0 | -1 | 1 | 0 |
| 30 Sep 21 | 0 | -1 | 1 | 0 |
| 30 Jun 21 | 0 | -1 | 1 | 0 |
| 31 Mar 21 | 0 | -1 | 1 | 0 |
| 31 Dec 20 | 0 | -1 | 1 | 0 |
| 30 Sep 20 | 0 | -2 | 1 | 0 |
| 30 Jun 20 | 0 | -2 | 1 | 0 |
| 31 Mar 20 | 0 | -2 | 1 | 0 |
| 31 Dec 19 | 0 | -2 | 2 | 0 |
| 30 Sep 19 | 0 | -2 | 2 | 0 |
| 30 Jun 19 | 0 | -2 | 2 | 0 |
| 31 Mar 19 | 0 | -2 | 2 | 0 |
| 31 Dec 18 | 0 | -2 | 2 | 0 |
| 30 Sep 18 | 0 | -2 | 2 | 0 |
| 30 Jun 18 | 1 | -2 | 2 | 0 |
| 31 Mar 18 | 1 | -3 | 2 | 0 |
| 31 Dec 17 | 0 | -3 | 3 | 0 |
| 31 Dec 16 | 0 | 0 | 0 | 0 |
Quality Earnings: IRX is currently unprofitable.
Growing Profit Margin: IRX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IRX is unprofitable, but has reduced losses over the past 5 years at a rate of 4.6% per year.
Accelerating Growth: Unable to compare IRX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IRX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).
Return on Equity
High ROE: IRX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.